Key paper on the impact of respiratory viral infections on lung function in bone marrow transplant patients published by my colleagues @fredhutch.org pubmed.ncbi.nlm.nih.gov/41027579/

Cheers to Chandler! Thanks for helping set up the @fredhutch.bsky.social VIDD-Clinical Research Center. Best wishes at OHSU. Looking forward to seeing the great things you will do there.

Walked up to my office the other day and this made me smile. Thanks lab, you guys are awesome @fredhutch.bsky.social

Obliteride 5k! #formydad #curecancerfaster #research @obliteride.bsky.social @fredhutch.bsky.social

I'm riding in the @obliteride.bsky.social this weekend to support cancer research and care @fredhutch.bsky.social. Check out my page and, if you'd like, make a donation that will fuel cancer research. secure.fredhutch.org/goto/Jim_Boon

Academic/industry partnerships @fredhutch.bsky.social through the Evergreen Fund drive innovation, collaboration, and research with real world impact. Grateful for the opportunity to accelerate antibody development to respiratory viruses for our transplant community www.fredhutch.org/en/news/rele...

Check out what's new from our lab @fredhutch.bsky.social www.biorxiv.org/content/10.1... with 1-minute audio summary sciencecast.org/casts/0aqdo7... We discovered a highly potent antibody that can be used as prevention and treatment for a common respiratory virus called human metapneumovirus.

I'm riding my single gear bike (donated by my brother) over the hills of Seattle in the @obliteride.bsky.social on August 9th to support the @fredhutch.bsky.social Cancer Center, where I work. Below is my personal page. If you would like, you can donate. My best. secure.fredhutch.org/site/TR?px=1...

Are you a workstudy college student or know one who is interested in a career in the biological sciences? Our lab has a position open for a lab aide. Application here: careers-fhcrc.icims.com/jobs/29313/l... Lab website: research.fredhutch.org/boonyaratana...

Francis Collins, former longtime director of the National Institutes of Health, announced Saturday that he has retired www.statnews.com/2025/03/01/n...

Flu season isn't over yet, & it's important for kids & adults to get vaccinated. “With COVID-19, we got used to the idea that the very old are the only people who are at risk for getting seriously ill," UCSF's Dr. Peter Chin-Hong says. But with flu, "it's... also the very young.” ucsfh.org/4i1baA0

Thanks for a fabulous and productive scientific, clinical, and patient centered Tandem2025 conference by @astct.bsky.social we’ll miss you Hawaii. Lab dinner at the beach before we return to Seattle.

Great talk and title by Elizabeth Eubanks “Raising the Epstein Barr” from @dukemedschool.bsky.social @astct.bsky.social on therapies for relapsed refractory EBV post-transplant lymphoproliferative disease. Calling on Andy McGuire Lab @fredhutch.bsky.social to develop your therapeutic antibodies!

Interesting results presented by Elizabeth Krantz from @joshhillmd.bsky.social team @fredhutch.bsky.social @astct.bsky.social Tandem2025. Overall antibody levels are low in CAR T recipients. Re-vaccination is important. The Boonya lab collaborated on the B cell analysis.

Highlights from Justine Ross’ presentation from @cityofhope.bsky.social on RSV infections at Tandem2025 @astct.bsky.social 1) most respiratory viral infections occur during months 1-3 post-CAR T-cell therapy; 2) we need studies on RSV mAbs and vaccines in transplant and cell therapy recipients

Engaging talk by Jen Adair @fredhutch.bsky.social Tandem2025 @astct.bsky.social on efforts to make cell and gene therapy available in low and middle income countries. Academic centers need to step up. Great to see my friend @cgtgaithersburg.bsky.social in the Global Gene Therapy Initiative

Fred Hutch at #Tandem25: Dr. Masumi Ueda Oshima to present results of a novel drug regimen that shows great promise in preventing #cGVHD after transplant in people who received nonmyeloablative or reduced-intensity conditioning to treat a blood cancer. bit.ly/411oqO2

Meet the next generation of hematology and oncology leaders! The Fred Hutch/UW Hematology-Oncology Fellows are at #Tandem25 presenting their latest findings in transplantation, cell therapies, immunology and more.🩸🔬🥼 Meeting highlights: bit.ly/4aTobco #OncSky

Brief lab excursion from @astct.bsky.social to hike up Diamond Head State Monument and appreciate the beauty of Hawaii.

Beautiful best oral abstract by Masumi Oshima @fredhutch.bsky.social in a giant ballroom @astct.bsky.social on how post-transplant cytoxan significantly reduces chronic graft vs host disease but increases rates of infection.

The Boonya lab @fredhutch.bsky.social Tandem2025 reception @astct.bsky.social Thanks Dr. Geoff Hill for hosting! The poke bar was delish!

Superb discussion around our poster on how GVHD prophylaxis and low antibody levels can increase risk for RSV infection after stem cell transplant @astct.bsky.social with Sara Pernikoff, Annie Clurman, Filipo Milano @fredhutch.bsky.social and Oriana Miltiadous @mskcancercenter.bsky.social

Fred Hutch at #Tandem25: Catch Dr. Fred Appelbaum present "How We Got Here: Don Thomas, Marrow Transplantation & the Cell Therapy Revolution." Details: bit.ly/4hz8OZc

Fred Hutch at #Tandem25: Catch presentations from Drs. Julie Boiko, Rachel Salit, @simone-minnie.bsky.social and Marie Bleakley on cGVHD biology, basic science of GVL and post-HCT immune microenvironment, T cell responses to minor histocompatibility antigens & more 👉 bit.ly/3EAM24L

Fantastic oral abstract by Stosh Ozog from @joshhillmd.bsky.social group @fredhutch.bsky.social @astct.bsky.social In CAR T-cell recipients, CD19 B cell counts are the primary predictor of vaccine responses (Sara Pernikoff in the Boonya Lab collaborated on this work)

Important new guidelines from @astct.bsky.social in the pipeline on diagnosis and management of parainfluenza and metapneumovirus respiratory infections after stem cell transplant or CAR T-cell therapy. Presented by Marjorie Batista. We need new vaccines and treatments for these common viruses.

Great talk by Dimitrios Kontoyiannis on “point” for mold prophylaxis after allogeneic transplant @astct.bsky.social

Lindsey Baden @astct.bsky.social on “counter-point” for mold prophylaxis after allogeneic transplant: “preemption not prophylaxis should be the goal”. Important point to consider attack rates and adverse events when deciding about prophylaxis.

Really informative talk by Marcel van den Brink on oral microbiome therapies, antibiotic stewardship, diet, and their effects on post transplant outcomes. Amazing amount of data on how we can harness the power of the microbiome @astct.bsky.social

The Boonya Lab @fredhutch.bsky.social is presenting results on RSV infections after stem cell transplant @astct.bsky.social Tandem2025 in Hawaii. Check out our poster (cropped so it’s a cliffhanger) in the exhibit hall tonight. Annie Clurman and Sara Pernikoff will be there to answer questions!

The deadline for abstract submissions and travel awards to attend Symposium on Infectious Diseases in Immunocompromised Hosts has been extended to January 22nd. Consider applying! It's a great opportunity to learn the cutting edge in the field www.fredhutch.org/en/events/sy...

The newest member of my family: my Asa-body

The past year at Fred Hutch has been marked by exceptional achievements and inspiring moments. We’ve collected pictures and stories throughout 2024 that highlight our commitment to advancing cancer research and patient care. 📸 bit.ly/4acCybL

Non-science post: this okazu pan from Umami Kushi in Rainier Beach, Seattle is heaven. And Johnny behind the counter saw how much I was enjoying them that he showed me a random act of kindness by giving me a free bulgogi pan. Kindness never tasted so delish. Nom nom nom 🤤 umamikushi.com

A former technician in the lab Kayla Howpo dropped off my favorite dessert of all time: crème brûlée! This made my day. Check out that caramelization. From her husband’s bakery La Fete on Mercer Island lafetepatisserie.com

Happy holidays! Lab holiday party, hosted by our postdoc Catherine Jacob Dolan. So grateful for this team of scientists. Notably, our significant others beat us at reverse charades

After safety signal in Moderna's trial forced vaccinemaker to end study FDA disclosed today that enrollment of young children is now "on hold for all clinical studies of RSV vaccine candidates under U.S. IND" www.fda.gov/media/184301...

Shopping at Costco for a lab holiday party on a Saturday…

Hi to my new followers! I am a virologist at @fredhutch.bsky.social in the team of Keith Jerome. If you are curious about what I do here are 3 options for you: 1. Read our latest paper! We showed that a viral gene drive propagated during HSV-1 infection in mice www.nature.com/articles/s41...

#RSV season is here, and infants are highly vulnerable. In a new proof-of-concept study, researchers in the McGuire Lab at Fred Hutch propose a vaccine strategy to activate pre-programmed immune cells in newborns, building immunity while supporting current treatments. bit.ly/3YTjfyI

Fred Hutch researchers just secured a $3.84m grant from the National Cancer Institute to learn more about how our immune systems respond to Kaposi sarcoma-associated herpesvirus. The findings could help guide development of a future cancer-preventive vaccine. bit.ly/4hZ944C

In a recent collaboration, Fred Hutch researchers helped show how antibodies target a critical protein used by malarial parasites to stick to blood vessels. The work could help guide development of vaccines designed to elicit similar protective responses.

Don't forget our upcoming 4th Symposium on Infectious Diseases in the Immunocompromised Host is coming this May 11-14th in Seattle! www.fredhutch.org/en/events/sy... Travel stipends for trainees www.fredhutch.org/en/events/sy... Abstract submission details here: www.fredhutch.org/en/events/sy...

When the -80°C freezer fails at 1AM

Come join our fantastic infectious disease team @fredhutch.bsky.social!